Diet composition and the metabolic syndrome: What is the optimal fat intake?

Scott M. Grundy, Nicola Abate, Manisha Chandalia

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Two cholesterol-raising fatty acids in the diet, saturated fatty acids and trans fatty acids, increase the serum low-density lipoprotein cholesterol concentration. This fact justifies the recommendation of a reduced intake of cholesterol-raising fatty acids. Emerging data suggest that diets higher in unsaturated fatty acids, particularly monounsaturated fatty acids, have several advantages over high-carbohydrate intakes. This advantage appears to hold, particularly for populations having a high prevalence of insulin resistance, such as the US population. If the US public were to modify its eating habits in the direction of better weight control and more exercise, higher intakes of carbohydrate might be better tolerated. At the same time, the experience with the Mediterranean population reveals that in healthier populations, diets relatively high in unsaturated fatty acids are well tolerated and are associated with a low prevalence of both coronary heart disease and type 2 diabetes.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
Volume113
Issue number9 SUPPL. 2
StatePublished - Dec 30 2002
Externally publishedYes

Fingerprint

Fats
Diet
Fatty Acids
Unsaturated Fatty Acids
Population
Cholesterol
Carbohydrates
Trans Fatty Acids
Monounsaturated Fatty Acids
Feeding Behavior
LDL Cholesterol
Type 2 Diabetes Mellitus
Coronary Disease
Insulin Resistance
Weights and Measures
Serum

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Grundy, S. M., Abate, N., & Chandalia, M. (2002). Diet composition and the metabolic syndrome: What is the optimal fat intake? American Journal of Medicine, 113(9 SUPPL. 2).

Diet composition and the metabolic syndrome : What is the optimal fat intake? / Grundy, Scott M.; Abate, Nicola; Chandalia, Manisha.

In: American Journal of Medicine, Vol. 113, No. 9 SUPPL. 2, 30.12.2002.

Research output: Contribution to journalArticle

Grundy, SM, Abate, N & Chandalia, M 2002, 'Diet composition and the metabolic syndrome: What is the optimal fat intake?', American Journal of Medicine, vol. 113, no. 9 SUPPL. 2.
Grundy, Scott M. ; Abate, Nicola ; Chandalia, Manisha. / Diet composition and the metabolic syndrome : What is the optimal fat intake?. In: American Journal of Medicine. 2002 ; Vol. 113, No. 9 SUPPL. 2.
@article{4a98489ebf86481a9a21b4944ba24e08,
title = "Diet composition and the metabolic syndrome: What is the optimal fat intake?",
abstract = "Two cholesterol-raising fatty acids in the diet, saturated fatty acids and trans fatty acids, increase the serum low-density lipoprotein cholesterol concentration. This fact justifies the recommendation of a reduced intake of cholesterol-raising fatty acids. Emerging data suggest that diets higher in unsaturated fatty acids, particularly monounsaturated fatty acids, have several advantages over high-carbohydrate intakes. This advantage appears to hold, particularly for populations having a high prevalence of insulin resistance, such as the US population. If the US public were to modify its eating habits in the direction of better weight control and more exercise, higher intakes of carbohydrate might be better tolerated. At the same time, the experience with the Mediterranean population reveals that in healthier populations, diets relatively high in unsaturated fatty acids are well tolerated and are associated with a low prevalence of both coronary heart disease and type 2 diabetes.",
author = "Grundy, {Scott M.} and Nicola Abate and Manisha Chandalia",
year = "2002",
month = "12",
day = "30",
language = "English (US)",
volume = "113",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "9 SUPPL. 2",

}

TY - JOUR

T1 - Diet composition and the metabolic syndrome

T2 - What is the optimal fat intake?

AU - Grundy, Scott M.

AU - Abate, Nicola

AU - Chandalia, Manisha

PY - 2002/12/30

Y1 - 2002/12/30

N2 - Two cholesterol-raising fatty acids in the diet, saturated fatty acids and trans fatty acids, increase the serum low-density lipoprotein cholesterol concentration. This fact justifies the recommendation of a reduced intake of cholesterol-raising fatty acids. Emerging data suggest that diets higher in unsaturated fatty acids, particularly monounsaturated fatty acids, have several advantages over high-carbohydrate intakes. This advantage appears to hold, particularly for populations having a high prevalence of insulin resistance, such as the US population. If the US public were to modify its eating habits in the direction of better weight control and more exercise, higher intakes of carbohydrate might be better tolerated. At the same time, the experience with the Mediterranean population reveals that in healthier populations, diets relatively high in unsaturated fatty acids are well tolerated and are associated with a low prevalence of both coronary heart disease and type 2 diabetes.

AB - Two cholesterol-raising fatty acids in the diet, saturated fatty acids and trans fatty acids, increase the serum low-density lipoprotein cholesterol concentration. This fact justifies the recommendation of a reduced intake of cholesterol-raising fatty acids. Emerging data suggest that diets higher in unsaturated fatty acids, particularly monounsaturated fatty acids, have several advantages over high-carbohydrate intakes. This advantage appears to hold, particularly for populations having a high prevalence of insulin resistance, such as the US population. If the US public were to modify its eating habits in the direction of better weight control and more exercise, higher intakes of carbohydrate might be better tolerated. At the same time, the experience with the Mediterranean population reveals that in healthier populations, diets relatively high in unsaturated fatty acids are well tolerated and are associated with a low prevalence of both coronary heart disease and type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0037203479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037203479&partnerID=8YFLogxK

M3 - Article

C2 - 12566135

AN - SCOPUS:0037203479

VL - 113

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 9 SUPPL. 2

ER -